Safety and Efficacy of Single-Dose Ketorolac for Postoperative Pain Management After Primary Palatoplasty: A Prospective Cohort Study With Historical Controls.

Jason R SteinEsperanza Mantilla-RivasMarudeen AivazMd Sohel RanaIshwarya Shradha MamidiBrynne A IchiujiMonica ManriqueGary F RogersJulia C FinkelAlbert K Oh

Published in: The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association (2021)

This is the first prospective study to evaluate the safety and efficacy of single-dose ketorolac after PP. Although lack of standardization between study and historical control groups may have precluded observation of an analgesic benefit, analysis demonstrated a single dose of ketorolac after PP is safe. Further investigations with more patients and different postoperative regimens may clarify the role of ketorolac in improving pain after PP.

Keyphrases

pain management
chronic pain
end stage renal disease
patients undergoing
ejection fraction
newly diagnosed
chronic kidney disease
neuropathic pain
prognostic factors
peritoneal dialysis
patient reported outcomes